A multicentre, randomised, double blind, placebo-controlled, parallel group trial of the effectiveness of the nocturnal use of a Temperature Controlled Laminar Airflow (TLA) device (Protexo®) in adults with poorly-controlled, severe allergic asthma: the LASER trial

Filter
Article

Search results